>glucagon-likepeptide1-(7-36)amide{Sp:Human,Mouse,Rat} | The C-terminal arginine is amidated. GLP-1 (7-36) amide is a N-terminally truncated fragment of GLP1 [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=17739&displayId=1", 960, 600)' title="1. Bonic A, Mackin RB. (2003) Protein Expr Purif. 28 (1): 15-24">1</a>,<a href='javascript:callRef("ReferenceDisplayForward?referenceId=17738&displayId=3", 960, 600)' title="3. RouillÃ© Y, Bianchi M, Irminger JC, Halban PA. (1997) FEBS Lett. 413 (1): 119-23">3</a>]. GLP-1 (7-36) amide is the more predominant fragment of the precursor 
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR
>lixisenatide | Carboxy terminal amidated. 
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK
>exendin-4 | Amidation of C-terminal serine residue 
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
>tirzepatide | X2 and X13 are &alpha;-amino isobutyric acid (Aib), S39 is L-serinamide, and K20 is N6-{N-(hydrogen icosanedioyl)-&gamma;-Glu-bis[iminobis(ethylenoxy)acetyl]}-Lysine | Original:YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS
YAEGTFTSDYSIALDKIAQKAFVQWLIAGGPSSGAPPPS
>glucagon{Sp:Human,Mouse,Rat} |  
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
>semaglutide |  
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG
>liraglutide | Amide bridge formed between lysine residue at position 20 and a glutamamic acid residue 
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG
>glucagon-likepeptide1-(7-37){Sp:Human,Mouse,Rat} |  
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
>exendin-3 |  
HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
>exendin-(9-39) |  
DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
